Gene · 4050
Papers2,481
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,481
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing. | Haematologica | 2022 | 34788985 | PubTator, text mining | PubMed |
| Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment/prevention of human prostate cancer. | Mol Carcinog | 2022 | 34727410 | PubTator, text mining | PubMed |
| Functional characterization of a novel tumor necrosis factor gene (TNF-New) in rock bream (Oplegnathus fasciatus). | Dev Comp Immunol | 2022 | 34600021 | PubTator, text mining | PubMed |
| Synovial single-cell heterogeneity, zonation and interactions: a patchwork of effectors in arthritis. | Rheumatology (Oxford) | 2022 | 34559213 | PubTator, text mining | PubMed |
| Phytochemicals Targeting Oxidative Stress, Interconnected Neuroinflammatory, and Neuroapoptotic Pathways Following Radiation. | Curr Neuropharmacol | 2022 | 34370636 | PubTator, text mining | PubMed |
| Single-cell analysis reveals innate lymphoid cell lineage infidelity in atopic dermatitis. | J Allergy Clin Immunol | 2022 | 34363841 | PubTator, text mining | PubMed |
Activated Peripheral Blood B Cells in Rheumatoid Arthritis and Their Relationship to Anti-Tumor Necrosis Factor Treatment and Response: A Randomized Clinical Trial of the Effects of Anti-Tumor Necrosis Factor on B Cells. | Arthritis Rheumatol | 2022 | 34347945 | PubTator, text mining | PubMed |
| Suppressor CD4+ T cells expressing HLA-G are expanded in the peripheral blood from patients with acute decompensation of cirrhosis. | Gut | 2022 | 34344786 | PubTator, text mining | PubMed |
| SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8 T cells. | medRxiv | 2022 | 34341799 | PubTator, text mining | PubMed |
| Mucosal vaccines - fortifying the frontiers. | Nat Rev Immunol | 2022 | 34312520 | PubTator, text mining | PubMed |
| Defective Early B Cell Tolerance Checkpoints in Patients With Systemic Sclerosis Allow the Production of Self Antigen-Specific Clones. | Arthritis Rheumatol | 2022 | 34279059 | PubTator, text mining | PubMed |
| Identification of Monocytes Associated with Severe COVID-19 in the PBMCs of Severely Infected Patients Through Single-Cell Transcriptome Sequencing. | Engineering (Beijing) | 2022 | 34150352 | PubTator, text mining | PubMed |
| Expansion of Fcγ Receptor IIIa-Positive Macrophages, Ficolin 1-Positive Monocyte-Derived Dendritic Cells, and Plasmacytoid Dendritic Cells Associated With Severe Skin Disease in Systemic Sclerosis. | Arthritis Rheumatol | 2022 | 34042322 | PubTator, text mining | PubMed |
| Extracellular Vesicles from Human Adipose-Derived Mesenchymal Stem Cells: A Review of Common Cargos. | Stem Cell Rev Rep | 2022 | 33904115 | PubTator, text mining | PubMed |
| Application value and challenge of traditional Chinese medicine carried by ZIF-8 in the therapy of ischemic stroke. | Ibrain | 2021 | 37786560 | PubTator, text mining | PubMed |
| Recombinant lactic acid bacteria as promising vectors for mucosal vaccination. | Exploration (Beijing) | 2021 | 37323212 | PubTator, text mining | PubMed |
| Mutual interaction of microbiota and host immunity during health and diseases. | Biophys Rep | 2021 | 37287759 | PubTator, text mining | PubMed |
| Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma. | Explor Target Antitumor Ther | 2021 | 36046090 | PubTator, text mining | PubMed |
| Confronting challenges to enterotoxigenic Escherichia coli vaccine development. | Front Trop Dis | 2021 | 35937717 | PubTator, text mining | PubMed |
| Malnutrition assessment methods in adult patients with tuberculosis: a systematic review. | BMJ Open | 2021 | 35344503 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4050/papers?page=34